198 related articles for article (PubMed ID: 3516923)
1. The menopause.
Gambrell RD
Invest Radiol; 1986 Apr; 21(4):369-78. PubMed ID: 3516923
[TBL] [Abstract][Full Text] [Related]
2. The menopause: benefits and risks of estrogen-progestogen replacement therapy.
Gambrell RD
Fertil Steril; 1982 Apr; 37(4):457-74. PubMed ID: 7040116
[TBL] [Abstract][Full Text] [Related]
3. Use of progestogen therapy.
Gambrell RD
Am J Obstet Gynecol; 1987 May; 156(5):1304-13. PubMed ID: 3578452
[TBL] [Abstract][Full Text] [Related]
4. Estrogen replacement therapy: indications and complications.
Judd HL; Meldrum DR; Deftos LJ; Henderson BE
Ann Intern Med; 1983 Feb; 98(2):195-205. PubMed ID: 6824255
[TBL] [Abstract][Full Text] [Related]
5. Cancer and the use of estrogens.
Gambrell RD
Int J Fertil; 1986; 31(2):112-3, 116-22. PubMed ID: 2875032
[TBL] [Abstract][Full Text] [Related]
6. Reduced incidence of endometrial cancer among postmenopausal women treated with progestogens.
Gambrell RD; Massey FM; Castaneda TA; Ugenas AJ; Ricci CA
J Am Geriatr Soc; 1979 Sep; 27(9):389-94. PubMed ID: 469150
[TBL] [Abstract][Full Text] [Related]
7. Use of progestogens in postmenopausal women.
Gambrell RD
Int J Fertil; 1989; 34(5):315-21. PubMed ID: 2571591
[TBL] [Abstract][Full Text] [Related]
8. Decreased incidence of breast cancer in postmenopausal estrogen-progestogen users.
Gambrell RD; Maier RC; Sanders BI
Obstet Gynecol; 1983 Oct; 62(4):435-43. PubMed ID: 6888821
[TBL] [Abstract][Full Text] [Related]
9. Update on hormone replacement therapy.
Gambrell RD
Am Fam Physician; 1992 Nov; 46(5 Suppl):87S-96S. PubMed ID: 1442475
[TBL] [Abstract][Full Text] [Related]
10. Use of the progestogen challenge test to reduce the risk of endometrial cancer.
Gambrell RD; Massey FM; Castaneda TA; Ugenas AJ; Ricci CA; Wright JM
Obstet Gynecol; 1980 Jun; 55(6):732-8. PubMed ID: 6446050
[TBL] [Abstract][Full Text] [Related]
11. Estrogen replacement in the menopause.
Utian WH
Obstet Gynecol Annu; 1979; 8():369-91. PubMed ID: 390456
[TBL] [Abstract][Full Text] [Related]
12. The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms.
Parish SJ; Gillespie JA
Postgrad Med; 2017 Apr; 129(3):340-351. PubMed ID: 28132583
[TBL] [Abstract][Full Text] [Related]
13. Sex steroids and cancer.
Gambrell RD
Obstet Gynecol Clin North Am; 1987 Mar; 14(1):191-206. PubMed ID: 3306519
[TBL] [Abstract][Full Text] [Related]
14. Estrogen replacement therapy--boon or bane? Current status of the controversy.
Cali RW
Postgrad Med; 1984 Mar; 75(4):279-86. PubMed ID: 6701132
[TBL] [Abstract][Full Text] [Related]
15. Endocrine problems in the menopause.
Hammond CB; ory SJ
Clin Obstet Gynecol; 1982 Mar; 25(1):19-38. PubMed ID: 7039902
[TBL] [Abstract][Full Text] [Related]
16. Exogenous estrogens and endometrial carcinoma: review and comments for the clinician.
Berger GS; Fowler WC
J Reprod Med; 1977 Apr; 18(4):177-80. PubMed ID: 870690
[TBL] [Abstract][Full Text] [Related]
17. Geriatric gynaecology.
Cheang A; Kottegoda SR; Ratnam SS
Ann Acad Med Singap; 1987 Jan; 16(1):66-73. PubMed ID: 3296937
[TBL] [Abstract][Full Text] [Related]
18. Menopausal endocrinology and management.
Korenman SG
Arch Intern Med; 1982 Jun; 142(6):1131-6. PubMed ID: 7046670
[TBL] [Abstract][Full Text] [Related]
19. Estrogen use in postmenopausal women--costs, risks, and benefits.
Weinstein MC
N Engl J Med; 1980 Aug; 303(6):308-16. PubMed ID: 6770270
[TBL] [Abstract][Full Text] [Related]
20. Perspective on prescribing conjugated estrogens/bazedoxifene for estrogen-deficiency symptoms of menopause: a practical guide.
Palacios S; Currie H; Mikkola TS; Dragon E
Maturitas; 2015 Apr; 80(4):435-40. PubMed ID: 25684082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
